Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Immunological Reviews is Scopus-indexed (Q1, CiteScore 17), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by Wiley-Blackwell Publishing Ltd.
Checked against the index lists dated .
ISSN 0105-2896Verify ISSN ↗1600-065XVerify ISSN ↗
Publisher: Wiley-Blackwell Publishing Ltd
Cost to publish: About US$5,000 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Immunology and Allergy | 17 / 234 | 92nd | Q1 |
| Immunology | 21 / 243 | 91st | Q1 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1969–present, best quartile Q1, CiteScore 17.
Immunological Reviews is Q1 in Immunology and Allergy (rank 17 of 234) and Q1 in Immunology (rank 21 of 243), by CiteScore 2025.
Immunological Reviews is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 17, which places it in quartile Q1 at the 92nd percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 3.945, quartile Q1, with an H-index of 273.
The publisher lists an article processing charge of about US$5,000 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Immunological Reviews is published by Wiley-Blackwell Publishing Ltd. Its print ISSN is 0105-2896 and its online ISSN is 1600-065X.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Immunological Reviews has an h-index of 322 and a 2-year mean of 10.44 citations per paper (OpenAlex). Its Scopus CiteScore is 17, quartile Q1. On 2-year citations it ranks #12 of 231 Scopus journals in Immunology and Allergy.
Immunological Reviews published 115 papers in 2025; its busiest recent year was 2024 with 136. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 99 research articles (2025–2026), authors are most often from United States (51.5%), United Kingdom (8.8%) and Germany (7.6%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 2 retracted papers are recorded (0.4 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.